Clinical trial
A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
NCT01830920 is registered in ClinicalTrials.gov with Thrasos Innovation, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Parallel-Group, Randomized, Double Blind, Adaptive Study Investigating the Safety and Efficacy of THR-184 in Patients at Increased Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
- Lead sponsor
- Thrasos Innovation, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- September 30, 2015
- Enrollment
- 452 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.